The chart below shows how CCRN performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CCRN sees a +3.86% change in stock price 10 days leading up to the earnings, and a -7.60% change 10 days following the report. On the earnings day itself, the stock moves by +0.55%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Stable Revenue Outlook: 1. Strong Revenue Guidance: Cross Country Healthcare anticipates fourth quarter revenue between $300 million and $310 million, consistent with third quarter performance, indicating stability in their business operations.
Home Care Staffing Revenue Growth: 2. Home Care Staffing Growth: Home care staffing revenue increased by 13% year-over-year in Q3 2024, with expectations for continued mid-teens growth in Q4, reflecting strong demand for aging in place services.
Physician Staffing Revenue Growth: 3. Physician Staffing Expansion: The physician staffing segment reported a 10% year-over-year revenue increase, with an annual run rate exceeding $200 million, driven by growth in billable days and higher revenue per day.
Cost Reduction Achievements: 4. Cost Management Success: Selling, general, and administrative expenses decreased by 10% sequentially and 22% year-over-year, demonstrating effective cost management strategies that enhance operational efficiency.
Share Repurchase Initiative: 5. Share Repurchase Program: The company repurchased over 800,000 shares for approximately $12 million in Q3, reflecting a commitment to returning value to shareholders while maintaining a strong balance sheet.
Negative
Revenue Decline Analysis: 1. Declining Revenue: Consolidated revenue for Q3 2024 was $315 million, down 7% sequentially and 29% year-over-year, primarily due to declines in Travel, Nurse, and Allied segments.
Gross Margin Decline: 2. Gross Margin Compression: Gross profit for the quarter was $64 million, resulting in a gross margin of 20.4%, which is down 40 basis points sequentially and 160 basis points year-over-year, attributed to bill pay spread compression in the travel business.
Adjusted EBITDA Decline: 3. Adjusted EBITDA Decline: Adjusted EBITDA for Q3 2024 was $10 million, reflecting a margin of 3.3%, indicating a decline in operating leverage due to lower revenue and gross margin pressures.
Travel Segment Revenue Decline: 4. Travel Business Downturn: Revenue from the Travel segment decreased by 11% sequentially and 41% year-over-year, driven by a decline in professionals on assignment and normalization in bill rates.
Education Revenue Decline: 5. Education Segment Decline: The education business reported a revenue decrease of 6% year-over-year and 37% sequentially, primarily due to the timing of school calendars.
Cross Country Healthcare, Inc. (CCRN) Q3 2024 Earnings Call Transcript
CCRN.O
0.17%